Status:
UNKNOWN
Polymorphisms in CD36 and STAT3 Genes and Different Dietary Interventions Among Patients With Coronary Artery Disease
Lead Sponsor:
Instituto de Cardiologia do Rio Grande do Sul
Collaborating Sponsors:
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
Background: Cardiovascular diseases are the major health problem worldwide and the understanding of genetic contributions on the development of cardiovascular diseases is increasing significantly. The...
Detailed Description
A randomized clinical trial with a nutrigenetic approach among patients ≥ 40 years diagnosed with CAD. Randomization will be made in blocks from a list of random numbers generated by site www.randomiz...
Eligibility Criteria
Inclusion
- Patients diagnosed with coronary arterial disease.
Exclusion
- Psychiatric disease;
- Morbid obesity (BMI ≥ 40mg/m2);
- Expectancy of life less than 6 months;
- Pregnancy or lactation;
- Renal failure (in dialysis);
- Congestive heart failure;
- Prior organ transplantation;
- Patients in wheelchair;
- Use of vitamin/nutritional supplements;
- Chronic use of non steroidal anti-inflammatory drugs;
- Participation in another experimental study.
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
204 Patients enrolled
Trial Details
Trial ID
NCT02202265
Start Date
August 1 2014
End Date
December 31 2020
Last Update
September 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto de Cardiologia/Fundação Universitária de Cardiologia (IC/FUC)
Porto Alegre, Rio Grande do Sul, Brazil, 90.620-001